Login or Sign Up
Glenmark Pharmaceuticals Ltd. Know Your Stock
15:57 Jul 31
Glenmark Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
68/100 High Financial Strength
Quality35/100 Mid Valuation
Valuation62/100 Technically Moderately Bullish
TechnicalSWOT
Strength
8
Weakness
6
Opportunity
1
Threat
0
60.22K
Market Cap (Cr)
57.52
PE Ratio
6.81
Price to Book Ratio
68.21
RSI
7.86 %
Net Profit Margin
Rating Based on 4 Analysts
Buy
50%
Hold
25%
Sell
25%
Buy
Analyst Price Target
The average price target is 1855 with a high estimate of 2430 and low estimate of 1620
Current 2134.10
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
